Collin Sexton

#2 SG

Utah Jazz

Status

GTD - Illness - Not Specified Expected Return: 2024-10-01

Previous game (@ GSW 4/7)

PTS

REB

AST

BLK

STL

Latest Collin Sexton news

Sexton (illness) will not play in Sunday's regular-season finale versus Golden State. Sexton's 2023-24 campaign comes to an end after 78 appearances, which yielded 18.7 points, 2.6 rebounds and 4.9 assists per game. Sexton's scoring volume climbed towards his 2020-21 standard, which was admittedly lofty at 24.3 points per game, but his facilitation this year jumps off the page as well, boasting a career-best 2.33 AST/TO ratio alongside a career-high 4.9 assists per game.

2023-24 Season Stats

PTS

REB

AST

BLK

STL

18.7

2.6

4.9

0.2

0.8

2.1

Career Averages

PTS

REB

AST

BLK

STL

18.9

2.8

3.6

0.1

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	78	51	26.6	18.7	2.6	4.9	0.2	0.8	2.1	4	1.6	4.2	39.4%	4.8	9.1	53.0%	6.5	13.3	48.7%	4.1	4.7	85.9%	0.9	1.7	2.0	2.3	-143	60.7%
2022-23	48	15	23.9	14.3	2.2	2.9	0.1	0.6	1.8	1	1.0	2.5	39.3%	3.9	7.2	54.6%	4.9	9.8	50.6%	3.4	4.1	81.9%	0.8	1.4	2.3	1.6	-28	61.6%
2021-22	11	11	28.7	16.0	3.3	2.1	0.0	0.9	2.8	0	1.0	4.1	24.4%	5.2	9.6	53.8%	6.2	13.7	45.0%	2.6	3.5	74.4%	1.2	2.1	2.3	0.7	-30	52.3%
2020-21	60	60	35.3	24.3	3.1	4.4	0.2	1.0	2.8	1	1.6	4.4	37.1%	7.1	14.0	50.8%	8.8	18.4	47.5%	5.2	6.4	81.5%	1.0	2.2	2.6	1.6	-376	57.3%
2019-20	65	65	33.0	20.8	3.1	3.0	0.1	1.0	2.4	0	1.5	3.9	38.0%	6.4	12.8	50.1%	7.9	16.7	47.2%	3.5	4.1	84.6%	0.9	2.2	2.2	1.2	-397	56.0%
2018-19	82	72	31.8	16.7	2.9	3.0	0.1	0.5	2.3	2	1.5	3.6	40.2%	4.9	11.1	44.0%	6.3	14.7	43.0%	2.6	3.1	83.9%	0.7	2.2	2.3	1.3	-672	52.0%
Career	344	274	30.2	18.9	2.8	3.6	0.1	0.8	2.3	8	1.5	3.8	38.3%	5.4	10.9	49.8%	6.9	14.7	46.9%	3.7	4.4	83.4%	0.9	2.0	2.3	1.6	-1646	56.8%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/19	SAC	L 116-113	24	24	5	5	0	0	0	3	2	66.7%	13	9	69.2%	16	11	68.8%	1	0	0.0%	1	4	0.0	+22	2	26	73.0%
10/16	NZB	W 114-94	11	8	2	1	0	0	1	0	0	0.0%	4	2	50.0%	4	2	50.0%	4	4	100.0%	0	2	1.0	+9	1	9	69.4%
10/14	POR	W 138-133	19	16	1	6	1	1	2	3	2	66.7%	4	1	25.0%	7	3	42.9%	8	8	100.0%	0	1	3.0	+6	2	19	76.0%
10/10	LAC	L 103-98	17	5	1	0	0	0	1	2	1	50.0%	3	0	0.0%	5	1	20.0%	2	2	100.0%	0	1	0.0	-14	2	2	42.5%
10/8	LAC	W 101-96	18	3	1	5	0	0	4	2	0	0.0%	4	1	25.0%	6	1	16.7%	2	1	50.0%	1	0	1.3	-4	1	0	21.8%
Preseason Totals			18.2	11.2	2.0	3.4	0.2	0.2	1.6	2.0	1.0	50.0%	5.6	2.6	46.4%	7.6	3.6	47.4%	3.4	3.0	88.2%	0.4	1.6	2.1	+19	1.6	13.6	61.6%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/7	GSW	L 118-110	27	15	2	7	1	1	3	2	0	0.0%	13	5	38.5%	15	5	33.3%	6	5	83.3%	0	2	2.3	-13	0	12	42.5%
4/5	LAC	L 131-102	17	12	3	2	0	0	2	6	2	33.3%	8	1	12.5%	14	3	21.4%	4	4	100.0%	3	0	1.0	-25	1	4	38.1%
4/2	CLE	L 129-113	34	19	3	7	0	0	7	5	2	40.0%	9	4	44.4%	14	6	42.9%	6	5	83.3%	1	2	1.0	-7	4	11	57.1%
3/31	SAC	L 127-106	28	22	1	4	0	1	2	3	1	33.3%	9	6	66.7%	12	7	58.3%	10	7	70.0%	0	1	2.0	-27	4	21	67.1%
3/29	HOU	L 101-100	44	29	6	5	2	0	4	4	0	0.0%	17	10	58.8%	21	10	47.6%	10	9	90.0%	2	4	1.3	+5	3	27	57.1%
3/27	SAS	L 118-111	38	26	2	9	1	2	3	6	2	33.3%	14	9	64.3%	20	11	55.0%	2	2	100.0%	1	1	3.0	+1	3	28	62.3%
3/25	DAL	L 115-105	29	20	2	6	0	0	1	6	3	50.0%	9	5	55.6%	15	8	53.3%	1	1	100.0%	1	1	6.0	-15	2	19	64.8%
3/23	HOU	L 147-119	35	20	2	8	0	2	0	2	1	50.0%	15	6	40.0%	17	7	41.2%	6	5	83.3%	1	1	0.0	-9	1	24	50.9%
3/21	DAL	L 113-97	33	20	4	5	0	0	3	3	0	0.0%	11	9	81.8%	14	9	64.3%	2	2	100.0%	1	3	1.7	-21	2	20	67.2%
3/20	OKC	L 119-107	29	25	5	7	0	2	2	2	0	0.0%	17	12	70.6%	19	12	63.2%	2	1	50.0%	1	4	3.5	-6	0	32	62.9%
3/18	MIN	L 114-104	36	24	1	2	0	0	4	8	5	62.5%	9	4	44.4%	17	9	52.9%	1	1	100.0%	1	0	0.5	-10	0	15	68.8%
3/16	MIN	L 119-100	30	22	2	10	0	1	5	3	1	33.3%	13	8	61.5%	16	9	56.3%	3	3	100.0%	1	1	2.0	-11	2	22	63.5%
3/15	ATL	W 124-122	31	21	4	6	0	2	1	6	3	50.0%	10	6	60.0%	16	9	56.3%	0	0	0.0%	0	4	6.0	+6	2	24	65.6%
3/12	BOS	L 123-107	31	20	7	5	1	0	5	4	1	25.0%	12	8	66.7%	16	9	56.3%	1	1	100.0%	5	2	1.0	-8	5	16	60.8%
3/9	DEN	L 142-121	35	17	1	4	0	1	0	3	1	33.3%	14	5	35.7%	17	6	35.3%	5	4	80.0%	1	0	0.0	-1	2	10	44.3%
3/6	CHI	L 119-117	34	24	4	7	0	0	2	11	5	45.5%	6	2	33.3%	17	7	41.2%	6	5	83.3%	0	4	3.5	+4	2	25	61.1%
3/4	WAS	W 127-115	33	29	3	7	0	2	1	7	4	57.1%	12	7	58.3%	19	11	57.9%	3	3	100.0%	2	1	7.0	+18	2	34	71.4%
3/2	MIA	L 126-120	31	18	1	5	0	0	0	1	0	0.0%	12	7	58.3%	13	7	53.8%	4	4	100.0%	0	1	0.0	-10	0	20	61.0%
2/29	ORL	L 115-107	29	19	3	4	0	1	1	5	3	60.0%	7	2	28.6%	12	5	41.7%	10	6	60.0%	0	3	4.0	-2	0	17	57.9%
2/27	ATL	L 124-97	29	22	1	3	0	6	3	6	3	50.0%	10	5	50.0%	16	8	50.0%	5	3	60.0%	0	1	1.0	-18	2	18	60.4%
2/25	SAS	W 128-109	26	16	2	10	0	4	4	0	0	0.0%	9	4	44.4%	9	4	44.4%	8	8	100.0%	1	1	2.5	+19	4	20	63.9%
2/22	CHA	L 115-107	26	17	2	5	0	0	4	4	2	50.0%	5	1	20.0%	9	3	33.3%	10	9	90.0%	0	2	1.3	+2	2	16	63.4%
2/15	GSW	L 140-137	33	35	3	9	1	1	3	8	3	37.5%	10	7	70.0%	18	10	55.6%	13	12	92.3%	1	2	3.0	+15	2	41	73.8%
2/14	LAL	L 138-122	26	18	0	3	2	0	0	5	2	40.0%	10	6	60.0%	15	8	53.3%	0	0	0.0%	0	0	0.0	-12	1	18	60.0%
2/12	GSW	L 129-107	26	22	6	5	0	0	2	3	2	66.7%	12	7	58.3%	15	9	60.0%	4	2	50.0%	2	4	2.5	-20	1	26	65.6%
2/8	PHX	L 129-115	24	19	4	8	1	0	5	6	3	50.0%	9	4	44.4%	15	7	46.7%	6	2	33.3%	2	2	1.6	-6	2	17	53.9%
2/6	OKC	W 124-117	26	14	0	4	0	0	2	3	1	33.3%	7	3	42.9%	10	4	40.0%	5	5	100.0%	0	0	2.0	+5	2	11	57.4%
2/4	MIL	W 123-108	25	19	1	3	0	0	4	7	3	42.9%	6	2	33.3%	13	5	38.5%	6	6	100.0%	0	1	0.8	-3	2	13	60.7%
2/1	PHI	L 127-124	24	22	1	6	1	1	3	4	2	50.0%	10	6	60.0%	14	8	57.1%	4	4	100.0%	0	1	2.0	-6	2	22	69.8%
1/30	NYK	L 118-103	27	22	3	7	0	0	2	4	2	50.0%	9	5	55.6%	13	7	53.8%	8	6	75.0%	2	1	3.5	-6	2	26	66.6%
1/29	BKN	L 147-114	23	6	1	7	0	0	2	2	0	0.0%	8	1	12.5%	10	1	10.0%	4	4	100.0%	0	1	3.5	-5	1	2	25.5%
1/27	CHA	W 134-122	35	24	4	13	0	2	3	7	3	42.9%	12	6	50.0%	19	9	47.4%	5	3	60.0%	2	2	4.3	+19	0	34	56.6%
1/25	WAS	W 123-108	16	11	3	6	0	1	2	2	1	50.0%	9	3	33.3%	11	4	36.4%	2	2	100.0%	1	2	3.0	+2	2	10	46.3%
1/23	NOP	L 153-124	23	22	3	7	1	0	1	4	2	50.0%	8	7	87.5%	12	9	75.0%	3	2	66.7%	0	3	7.0	-15	0	30	82.6%
1/20	HOU	L 127-126	40	28	3	5	0	2	2	7	2	28.6%	20	9	45.0%	27	11	40.7%	4	4	100.0%	3	0	2.5	+12	4	21	48.7%
1/18	OKC	L 134-129	34	31	1	7	0	1	2	7	4	57.1%	12	6	50.0%	19	10	52.6%	10	7	70.0%	1	0	3.5	+4	4	28	66.2%
1/15	IND	W 132-105	24	30	3	5	0	0	1	5	4	80.0%	12	7	58.3%	17	11	64.7%	4	4	100.0%	1	2	5.0	+14	2	33	80.0%
1/13	LAL	W 132-125	27	27	4	5	0	0	1	4	1	25.0%	9	7	77.8%	13	8	61.5%	10	10	100.0%	1	3	5.0	+18	5	31	77.6%
1/12	TOR	W 145-113	20	20	2	5	0	2	2	3	3	100.0%	7	2	28.6%	10	5	50.0%	8	7	87.5%	0	2	2.5	+15	0	24	74.0%
1/10	DEN	W 124-111	21	22	2	4	1	1	1	4	2	50.0%	10	6	60.0%	14	8	57.1%	4	4	100.0%	1	1	4.0	+11	3	20	69.8%
1/8	MIL	W 132-116	18	19	0	3	0	1	0	6	3	50.0%	7	5	71.4%	13	8	61.5%	0	0	0.0%	0	0	0.0	+1	0	17	73.1%
1/6	PHI	W 120-109	27	22	3	10	0	0	5	3	1	33.3%	11	8	72.7%	14	9	64.3%	4	3	75.0%	1	2	2.0	+7	3	23	69.8%
1/5	BOS	L 126-97	20	13	1	3	0	3	3	3	0	0.0%	9	5	55.6%	12	5	41.7%	3	3	100.0%	0	1	1.0	-13	1	7	48.8%
1/3	DET	W 154-148	30	25	2	5	0	1	0	2	1	50.0%	12	6	50.0%	14	7	50.0%	10	10	100.0%	1	1	0.0	+2	5	28	67.9%
1/1	DAL	W 127-90	18	8	3	6	0	0	1	3	0	0.0%	5	2	40.0%	8	2	25.0%	4	4	100.0%	1	2	6.0	+1	1	11	41.0%
12/30	MIA	W 117-109	25	22	2	5	0	1	3	4	1	25.0%	10	7	70.0%	14	8	57.1%	6	5	83.3%	1	1	1.7	-2	1	24	66.1%
12/28	NOP	L 112-105	30	26	5	3	0	0	0	6	3	50.0%	11	5	45.5%	17	8	47.1%	9	7	77.8%	1	4	0.0	+3	4	18	62.0%
12/26	SAS	W 130-118	28	20	3	6	1	1	1	2	0	0.0%	8	8	100.0%	10	8	80.0%	5	4	80.0%	0	3	6.0	-7	4	26	82.0%
12/23	TOR	W 126-119	24	16	0	3	0	1	1	2	1	50.0%	9	4	44.4%	11	5	45.5%	6	5	83.3%	0	0	3.0	-11	0	13	58.7%
12/21	DET	W 119-111	32	19	4	8	0	4	3	3	1	33.3%	15	5	33.3%	18	6	33.3%	6	6	100.0%	3	1	2.7	-10	3	16	46.0%
12/20	CLE	L 124-116	33	20	3	2	1	0	2	6	3	50.0%	11	4	36.4%	17	7	41.2%	4	3	75.0%	0	3	1.0	+6	5	11	53.3%
12/18	BKN	W 125-108	35	27	3	6	0	0	2	7	3	42.9%	10	3	30.0%	17	6	35.3%	13	12	92.3%	1	2	3.0	+18	3	25	59.4%
12/16	SAC	L 125-104	32	28	3	1	0	1	1	6	2	33.3%	12	8	66.7%	18	10	55.6%	7	6	85.7%	1	2	1.0	-27	2	24	66.4%
12/14	POR	W 122-114	31	27	2	4	0	1	2	5	2	40.0%	12	9	75.0%	17	11	64.7%	3	3	100.0%	1	1	2.0	+17	2	27	73.7%
12/13	NYK	W 117-113	30	26	4	7	0	0	2	8	3	37.5%	10	7	70.0%	18	10	55.6%	3	3	100.0%	1	3	3.5	-9	4	25	67.3%
12/11	OKC	L 134-120	26	20	4	2	0	2	0	4	1	25.0%	9	6	66.7%	13	7	53.8%	6	5	83.3%	2	2	0.0	-1	1	24	63.9%
12/8	LAC	L 117-103	17	13	3	3	0	1	1	4	1	25.0%	8	4	50.0%	12	5	41.7%	2	2	100.0%	0	3	3.0	-1	2	8	50.5%
12/6	DAL	L 147-97	17	7	3	5	0	1	2	1	0	0.0%	3	0	0.0%	4	0	0.0%	8	7	87.5%	0	3	2.5	-3	1	12	46.5%
12/2	POR	W 118-113	30	25	4	5	0	0	3	2	0	0.0%	11	9	81.8%	13	9	69.2%	7	7	100.0%	1	3	1.7	+4	2	28	77.7%
11/30	MIN	L 101-90	23	14	3	4	0	0	3	2	1	50.0%	6	3	50.0%	8	4	50.0%	5	5	100.0%	0	3	1.3	-3	1	18	68.6%
11/29	MEM	L 105-91	22	9	1	3	0	1	2	4	1	25.0%	6	2	33.3%	10	3	30.0%	3	2	66.7%	1	0	1.5	-3	3	1	39.8%
11/27	NOP	W 114-112	17	11	2	0	0	2	4	6	3	50.0%	3	1	33.3%	9	4	44.4%	0	0	0.0%	1	1	0.0	+6	2	5	61.1%
11/25	NOP	W 105-100	28	16	3	6	0	0	2	8	3	37.5%	5	2	40.0%	13	5	38.5%	4	3	75.0%	2	1	3.0	+3	0	16	54.2%
11/22	POR	L 121-105	11	1	2	2	0	1	2	3	0	0.0%	2	0	0.0%	5	0	0.0%	2	1	50.0%	1	1	1.0	-16	2	3	8.5%
11/21	LAL	L 131-99	21	14	3	4	0	0	1	3	2	66.7%	8	4	50.0%	11	6	54.5%	0	0	0.0%	0	3	4.0	-9	2	11	63.6%
11/19	PHX	L 140-137	22	18	5	2	0	1	2	6	3	50.0%	7	3	42.9%	13	6	46.2%	3	3	100.0%	3	2	1.0	+12	0	17	62.8%
11/17	PHX	L 131-128	20	8	4	4	2	0	0	2	0	0.0%	6	3	50.0%	8	3	37.5%	2	2	100.0%	2	2	0.0	-6	3	11	45.0%
11/14	POR	W 115-99	28	13	4	7	1	2	2	5	1	20.0%	6	4	66.7%	11	5	45.5%	2	2	100.0%	0	4	3.5	+14	3	17	54.7%
11/10	MEM	W 127-121	17	10	2	6	0	1	3	2	0	0.0%	6	3	50.0%	8	3	37.5%	4	4	100.0%	1	1	2.0	+3	0	11	51.2%
11/8	IND	L 134-118	15	10	2	2	0	0	0	2	1	50.0%	7	2	28.6%	9	3	33.3%	3	3	100.0%	0	2	0.0	-7	0	9	48.4%
11/6	CHI	L 130-113	16	14	3	2	0	0	1	3	1	33.3%	7	5	71.4%	10	6	60.0%	1	1	100.0%	1	2	2.0	+1	3	12	67.0%
11/4	MIN	L 123-95	18	7	4	4	1	0	6	3	1	33.3%	0	0	0.0%	3	1	33.3%	4	4	100.0%	2	2	0.7	-14	2	10	73.5%
11/2	ORL	L 115-113	16	10	1	1	0	0	2	2	0	0.0%	6	3	50.0%	8	3	37.5%	6	4	66.7%	1	0	0.5	-5	1	2	47.0%
11/1	MEM	W 133-109	22	23	3	6	0	0	2	6	4	66.7%	4	4	100.0%	10	8	80.0%	3	3	100.0%	1	2	3.0	+22	1	29	101.6%
10/30	DEN	L 110-102	16	12	0	0	0	0	1	5	2	40.0%	5	3	60.0%	10	5	50.0%	0	0	0.0%	0	0	0.0	-10	2	5	60.0%
10/28	PHX	L 126-104	23	14	2	6	0	0	2	0	0	0.0%	8	4	50.0%	8	4	50.0%	6	6	100.0%	1	1	3.0	-7	1	17	65.8%
10/27	LAC	W 120-118	19	13	1	0	0	0	0	2	0	0.0%	10	5	50.0%	12	5	41.7%	4	3	75.0%	0	1	0.0	-4	3	6	47.2%
10/25	SAC	L 130-114	19	9	3	0	0	0	3	2	0	0.0%	7	2	28.6%	9	2	22.2%	7	5	71.4%	0	3	0.0	-10	3	2	37.3%
Regular Season Totals			26.6	18.7	2.6	4.9	0.2	0.8	2.1	4.2	1.6	39.4%	9.1	4.8	53.0%	13.3	6.5	48.7%	4.7	4.1	85.9%	0.9	1.7	2.3	-144	2.0	21.4	60.7%

Collin Sexton

#2 SG

Status

Previous game (@ GSW 4/7)

Latest Collin Sexton news

Out due to illness

2023-24 Season Stats

Collin Sexton Career Stats

Career Averages

Collin Sexton Season Stats 2023-24

Previous Game (@ GSW 4/7)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

Collin Sexton Game Log 2023-24

Collin Sexton Player Profile

Career History

Collin Sexton Fantasy Projections

It's the offseason! 😎

Collin Sexton Latest News

Out due to illness

Questionable for Sunday

Won't play Friday

Considered doubtful for Friday

Out again Thursday

Ruled out for Tuesday

Downgraded to questionable

Posts 15 points in loss

Scores 29 in loss to Houston

Collin Sexton

#2 SG

Unlock the latest Utah Jazz news — direct to your inbox.

Status

Previous game (@ GSW 4/7)

Latest Collin Sexton news Subscribe

2023-24 Season Stats

Latest Collin Sexton news